Jeff Geschwind, MD: Cancer Drug Developer Founder of Cage Pharma, Jeff Geschwind, MD, focuses on glycolysis-targeting cancer drugs. His research disrupts tumor metabolism, offering new hope for aggressive cancers. https://www.linkedin.com/in/jeff-geschwind-037200174